You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pompe

Showing 26 - 50 of 155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

Recruiting
  • Glycogen Storage Disease Type II
  • Alglucosidase alfa GZ419829
  • Leuven, Belgium
  • +8 more
Jan 17, 2023

Pompe Disease Infantile-Onset Trial in Italy, Taiwan, United States (ATB200, AT2221)

Available
  • Pompe Disease Infantile-Onset
  • Oakland, California
  • +3 more
Jul 18, 2022

Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Israel, United States

Terminated
Has Results
  • Pompe Disease
  • +2 more
  • Myozyme® (alglucosidase alfa)
  • Louisville, Kentucky
  • +4 more
Mar 24, 2022

Glycogen Storage Disease Type II-Pompe's Disease Trial in Worldwide (Avalglucosidase alfa (GZ402666), Alglucosidase alfa

Active, not recruiting
Has Results
  • Glycogen Storage Disease Type II-Pompe's Disease
  • Avalglucosidase alfa (GZ402666)
  • Alglucosidase alfa (GZ419829)
  • Valhalla, New York
  • +9 more
May 3, 2022

Glycogen Storage Disease Type II Trial in France (Avalglucosidase alfa (GZ402666))

Recruiting
  • Glycogen Storage Disease Type II
  • Avalglucosidase alfa (GZ402666)
  • Brest, France
  • +9 more
Jul 22, 2022

Pompe Disease, Glycogen Storage Disease Type II (GSD II) Trial in Worldwide (alglucosidase alfa)

Completed
Has Results
  • Pompe Disease
  • Glycogen Storage Disease Type II (GSD II)
  • alglucosidase alfa
  • Valhalla, New York
  • +11 more
Mar 15, 2022

Higher Dose of Alglucosidase Alpha for Pompe Disease

Not yet recruiting
  • Glycogen Storage Disease Type II
  • Alglucosidase Alfa
  • (no location specified)
Aug 17, 2021

CRIM Status and Longitudinal Follow-up of Individuals With Pompe

Recruiting
  • Pompe Disease
  • Observational
  • Durham, North Carolina
    Duke University Medical Center
Sep 16, 2021

Avalglucosidase Alfa Pregnancy Study

Recruiting
  • Pompe Disease
  • Pregnancy
  • avalglucosidase alfa-NGPT (GZ402666) IV
  • avalglucosidase alfa-NGPT (GZ402666)
  • Bridgewater, New Jersey
    Investigational site worldwide
Feb 15, 2023

Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2 Trial in Worldwide (SPK-3006)

Active, not recruiting
  • Pompe Disease
  • +6 more
  • SPK-3006
  • Phoenix, Arizona
  • +28 more
Jul 22, 2022

Patients With Juvenile-onset Pompe Disease

Recruiting
  • Pompe's Disease Juvenile Onset
    • Nancy, France
      Children's Hospital - CHRU de Nancy
    Jul 2, 2021

    Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease

    Completed
    • Pompe Disease
    • Thoracic MRI
    • +5 more
    • Gainesville, Florida
      University of Florida
    Jun 28, 2021

    Screen of Childhood Late-onset Pompe Disease in Pediatric

    Not yet recruiting
    • Pompe Disease
      • Taipei, Taiwan
        Wen-Chin Weng
      Jul 21, 2021

      Identification of Tongue Involvement in Late-Onset Pompe Disease

      Completed
      • Myopathy
      • +2 more
      • Observational study
      • Durham, North Carolina
        Duke University Medical Center
      Jul 2, 2021

      Glycogen Storage Disease Trial in Durham (Lingual Muscle Training)

      Completed
      • Glycogen Storage Disease
      • Lingual Muscle Training
      • Durham, North Carolina
        Duke University Medical Center and affiliated practices
      Jul 27, 2021

      Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

      Recruiting
      • Mucopolysaccharidosis I
      • +7 more
      • There is no intervention
      • San Francisco, California
        University of California San Francisco
      Nov 9, 2022

      Pompe Disease, Glycogen Storage Disease Type II, Lysosomal Storage Diseases Trial in Gainesville (Diet and Exercise)

      Completed
      • Pompe Disease
      • +2 more
      • Diet and Exercise
      • Gainesville, Florida
        University of Florida Clinical Research Center
      May 13, 2021

      Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage

      Recruiting
      • Glycogen Storage Disease
      • +2 more
      • No intervention
      • Copenhagen, Copenhange, Denmark
        Neuromuscular Research Unit, 8077
      Oct 26, 2022

      Long-Term Development of Muscular Dystrophy Outcome Assessments

      Not yet recruiting
      • LGMD1A
      • +33 more
        • Richmond, Virginia
          Virginia Commonwealth University
        Aug 3, 2023

        Glycogen Storage Disease Type II Pompe Disease Trial in Worldwide (GZ402666)

        Completed
        • Glycogen Storage Disease Type II Pompe Disease
        • Phoenix, Arizona
        • +16 more
        Dec 14, 2022

        Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

        Recruiting
        • Glycogen Storage Disease Type II Infantile Onset
        • Gainesville, Florida
          University of Florida Clinical Research Center
        Jan 18, 2023

        Late-onset Pompe Disease Treated Beyond 36 Months

        Completed
        • Pompe Disease
        • glucosidase alfa
        • Munich, Bavaria, Germany
        • +2 more
        Feb 5, 2021

        Enzyme Replacement Therapy in Pediatric Pompe Disease.

        Recruiting
        • Pompe Disease Infantile-Onset
        • Cardiopulmonary exercise testing (CPET)
        • Haifa, Israel
          Rambam Medical Center
        Feb 14, 2021

        Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2 Trial in Worldwide (Neutralizing Antibody to SPK-3006

        Completed
        • Pompe Disease
        • +5 more
        • Neutralizing Antibody to SPK-3006 capsid
        • Phoenix, Arizona
        • +17 more
        Jul 14, 2021

        Biomarker for Pompe Disease (BioPompe)

        Active, not recruiting
        • Cardiac Diseases
        • +6 more
          • Rostock, Germany
          • +3 more
          May 12, 2021